Vytrus Biotech SA
MAD:VYT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Vytrus Biotech SA
MAD:VYT
|
ES |
|
EGPI Firecreek Inc
OTC:EFIR
|
US |
|
H
|
Hargreaves Lansdown PLC
LSE:HL
|
UK |
|
PAR Technology Corp
NYSE:PAR
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is VYT's stock price target?
Not Available
VYT doesn't have any price targets made by Wall Street professionals.
What is Vytrus Biotech SA's Revenue forecast?
Projected CAGR
32%
For the last 5 years the
compound annual growth rate for
Vytrus Biotech SA's revenue is
33%.
The projected
CAGR
for the next 4 years is
32%.
What is Vytrus Biotech SA's Operating Income forecast?
Projected CAGR
60%
The
compound annual growth rate
of Vytrus Biotech SA's operating income for the next 4 years is
60%.
What is Vytrus Biotech SA's Net Income forecast?
Projected CAGR
52%
The
compound annual growth rate
of Vytrus Biotech SA's net income for the next 4 years is
52%.
